Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs
Clinical trial NCT04980027 · COMPLETED
Trial details
- NCT number
- NCT04980027
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2022-12-23
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.